Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms

Immune checkpoint inhibitors (ICIs) have revolutionized the field of anti-cancer therapy over the last decade; they provide durable clinical responses against tumors by inhibiting immune checkpoint proteins that canonically regulate the T cell-mediated immune response. Despite their success in many...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Gwenyth J., Johnson, Douglas B., Johnson, Rachelle W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568292/
https://www.ncbi.nlm.nih.gov/pubmed/37842554
http://dx.doi.org/10.1016/j.jbo.2023.100505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568292/
https://www.ncbi.nlm.nih.gov/pubmed/37842554
http://dx.doi.org/10.1016/j.jbo.2023.100505

Ejemplares similares